PLoS Pathogens,
Год журнала:
2021,
Номер
17(12), С. e1010106 - e1010106
Опубликована: Дек. 30, 2021
The
development
of
safe
and
effective
vaccines
in
a
record
time
after
the
emergence
Severe
Acute
Respiratory
Syndrome
Coronavirus
2
(SARS-CoV-2)
is
remarkable
achievement,
partly
based
on
experience
gained
from
multiple
viral
outbreaks
past
decades.
However,
Disease
2019
(COVID-19)
crisis
also
revealed
weaknesses
global
pandemic
response
large
gaps
that
remain
our
knowledge
biology
coronaviruses
(CoVs)
influenza
viruses,
major
respiratory
viruses
with
potential.
Here,
we
review
current
knowns
unknowns
CoVs,
highlight
common
research
challenges
they
pose
3
areas:
mechanisms
adaptation
to
humans,
physiological
molecular
determinants
disease
severity,
control
strategies.
We
outline
multidisciplinary
approaches
technological
innovations
need
be
harnessed
order
improve
preparedeness
next
pandemic.
Cold Spring Harbor Perspectives in Medicine,
Год журнала:
2022,
Номер
12(5), С. a041390 - a041390
Опубликована: Апрель 20, 2022
Our
understanding
of
the
still
unfolding
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
pandemic
would
have
been
extremely
limited
without
study
genetics
and
evolution
this
new
human
coronavirus.
Large-scale
genome-sequencing
efforts
provided
close
to
real-time
tracking
global
spread
diversification
SARS-CoV-2
since
its
entry
into
population
in
late
2019.
These
data
underpinned
analysis
origins,
epidemiology,
adaptations
population:
principally
immune
evasion
increasing
transmissibility.
SARS-CoV-2,
despite
being
a
pathogen,
was
highly
capable
human-to-human
transmission.
During
rapid
humans,
has
evolved
independent
forms,
so-called
"variants
concern,"
that
are
better
optimized
for
The
most
important
adaptation
bat
progenitor
both
SARS-CoV-1
infection
(and
other
mammals)
is
use
angiotensin-converting
enzyme
(ACE2)
receptor.
Relaxed
structural
constraints
provide
plasticity
SARS-related
spike
protein
permitting
it
accommodate
significant
amino
acid
replacements
antigenic
consequence
compromising
ability
bind
ACE2.
Although
bulk
research
justifiably
concentrated
on
viral
as
main
determinant
changes
transmissibility,
there
accumulating
evidence
contribution
regions
proteome
virus-host
interaction.
Whereas
levels
community
transmission
recombinants
genetically
distinct
variants
at
present
low,
when
divergent
cocirculate,
recombination
between
clades
detected,
risk
viruses
with
properties
emerge.
Applying
computational
machine
learning
methods
genome
sequence
sets
generate
experimentally
verifiable
predictions
will
serve
an
early
warning
system
novel
variant
surveillance
be
future
vaccine
planning.
Omicron,
latest
concern,
focused
attention
step
change
events,
"shift,"
opposed
incremental
"drift"
antigenicity.
Both
increase
transmissibility
shift
Omicron
led
readily
causing
infections
fully
vaccinated
and/or
previously
infected.
Omicron's
virulence,
while
reduced
relative
concern
replaced,
Delta,
very
much
premised
past
exposure
individuals
clear
signal
boosted
vaccination
protects
from
disease.
Currently,
proven
itself
dangerous
pathogen
unpredictable
evolutionary
capacity,
leading
too
great
not
ensure
all
world
screened
by
sequencing,
protected
through
available
affordable
vaccines,
non-punitive
strategies
place
detecting
responding
concern.
Emerging Microbes & Infections,
Год журнала:
2021,
Номер
11(1), С. 95 - 112
Опубликована: Ноя. 29, 2021
SARS-CoV-2
was
first
reported
circulating
in
human
populations
December
2019
and
has
since
become
a
global
pandemic.
Recent
history
involving
SARS-like
coronavirus
outbreaks
have
demonstrated
the
significant
role
of
intermediate
hosts
viral
maintenance
transmission.
Evidence
natural
infection
experimental
infections
wide
variety
animal
species
been
demonstrated,
Viruses,
Год журнала:
2023,
Номер
15(4), С. 944 - 944
Опубликована: Апрель 10, 2023
The
COVID-19
pandemic
caused
by
SARS-CoV-2
is
associated
with
a
lower
fatality
rate
than
its
SARS
and
MERS
counterparts.
However,
the
rapid
evolution
of
has
given
rise
to
multiple
variants
varying
pathogenicity
transmissibility,
such
as
Delta
Omicron
variants.
Individuals
advanced
age
or
underlying
comorbidities,
including
hypertension,
diabetes
cardiovascular
diseases,
are
at
higher
risk
increased
disease
severity.
Hence,
this
resulted
in
an
urgent
need
for
development
better
therapeutic
preventive
approaches.
This
review
describes
origin
human
coronaviruses,
particularly
well
sub-variants.
Risk
factors
that
contribute
severity
implications
co-infections
also
considered.
In
addition,
various
antiviral
strategies
against
COVID-19,
novel
repurposed
drugs
targeting
viral
host
proteins,
immunotherapeutic
strategies,
discussed.
We
critically
evaluate
current
emerging
vaccines
their
efficacy,
immune
evasion
new
impact
on
diagnostic
testing
examined.
Collectively,
global
research
public
health
authorities,
along
all
sectors
society,
prepare
upcoming
future
coronavirus
outbreaks.
Nature Communications,
Год журнала:
2023,
Номер
14(1)
Опубликована: Авг. 28, 2023
Abstract
The
zoonotic
origin
of
the
COVID-19
pandemic
virus
highlights
need
to
fill
vast
gaps
in
our
knowledge
SARS-CoV-2
ecology
and
evolution
non-human
hosts.
Here,
we
detected
that
was
introduced
from
humans
into
white-tailed
deer
more
than
30
times
Ohio,
USA
during
November
2021-March
2022.
Subsequently,
deer-to-deer
transmission
persisted
for
2–8
months,
disseminating
across
hundreds
kilometers.
Newly
developed
Bayesian
phylogenetic
methods
quantified
how
is
not
only
three-times
faster
compared
rate
observed
but
also
driven
by
different
mutational
biases
selection
pressures.
long-term
effect
this
accelerated
evolutionary
remains
be
seen
as
no
critical
phenotypic
changes
were
animal
models
using
viruses.
Still,
has
transmitted
populations
a
relatively
short
duration,
risk
future
may
have
serious
consequences
livestock.
Ecology Letters,
Год журнала:
2022,
Номер
25(6), С. 1534 - 1549
Опубликована: Март 22, 2022
The
SARS-CoV-2
pandemic
has
led
to
increased
concern
over
transmission
of
pathogens
from
humans
animals,
and
its
potential
threaten
conservation
public
health.
To
assess
this
threat,
we
reviewed
published
evidence
human-to-wildlife
events,
with
a
focus
on
how
such
events
could
animal
human
We
identified
97
verified
examples,
involving
wide
range
pathogens;
however,
reported
hosts
were
mostly
non-human
primates
or
large,
long-lived
captive
animals.
Relatively
few
documented
examples
resulted
in
morbidity
mortality,
very
maintenance
pathogen
new
reservoir
subsequent
"secondary
spillover"
back
into
humans.
discuss
limitations
the
literature
surrounding
these
phenomena,
including
strong
sampling
bias
towards
human-proximate
mammals
possibility
systematic
against
reporting
parasites
wildlife,
both
which
limit
our
ability
risk
transmission.
outline
researchers
can
collect
experimental
observational
that
will
expand
capacity
for
assessment
Spike
(S)
protein
is
the
primary
antigenic
target
for
neutralization
and
vaccine
development
severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2).
It
decorates
virus
surface
undergoes
large
motions
of
its
receptor
binding
domains
(RBDs)
to
enter
host
cell.
Here,
we
observe
Down,
one-Up,
one-Open,
two-Up-like
structures
in
enhanced
molecular
dynamics
simulations,
characterize
transition
pathways
via
inter-domain
interactions.
Transient
salt-bridges
between
RBDA
RBDC
interaction
with
glycan
at
N343B
support
from
Down
one-Up.
Reduced
interactions
RBDB
one-Up
induce
toward
two-Up.
The
simulations
overall
agree
cryo-electron
microscopy
structure
distributions
FRET
experiments
provide
hidden
functional
structures,
namely,
intermediates
along
Down-to-one-Up
druggable
cryptic
pockets
as
well
one-Open
a
maximum
exposed
RBD.
inherent
flexibility
S-protein
thus
provides
essential
information
antiviral
drug
rational
design
or
development.
Viruses,
Год журнала:
2023,
Номер
15(2), С. 578 - 578
Опубликована: Фев. 20, 2023
The
coronavirus
disease
2019
(COVID-19)
pandemic
has
had
irreversible
and
devastating
impacts
on
every
aspect
of
human
life.
To
better
prepare
for
the
next
similar
pandemic,
a
clear
understanding
biology
is
prerequisite.
Nevertheless,
high-risk
nature
causative
agent
COVID-19,
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
requires
use
cumbersome
biosafety
level-3
(BSL-3)
confinement
facility.
facilitate
development
preventive
therapeutic
measures
against
SARS-CoV-2,
one
endemic
strains
low-risk
coronaviruses
gained
attention
as
useful
research
alternative:
OC43
(HCoV-OC43).
In
this
review,
its
history,
classification,
clinical
manifestations
are
first
summarized.
characteristics
viral
genomes,
genes,
evolution
process
then
further
explained.
addition,
host
factors
necessary
to
support
life
cycle
HCoV-OC43
innate,
well
adaptive,
immunological
responses
infection
discussed.
Finally,
in
vitro
vivo
systems
study
application
discovery
potential
antivirals
COVID-19
by
using
models
also
presented.
This
review
should
serve
concise
guide
those
who
wish
setting.
Annual Review of Animal Biosciences,
Год журнала:
2023,
Номер
11(1), С. 1 - 31
Опубликована: Фев. 15, 2023
Over
the
past
three
decades,
coronavirus
(CoV)
diseases
have
impacted
humans
more
than
any
other
emerging
infectious
disease.
The
recent
emergence
of
severe
acute
respiratory
syndrome
2
(SARS-CoV-2),
causative
agent
COVID-19
(coronavirus
disease
2019),
has
resulted
in
huge
economic
disruptions
and
loss
human
lives.
SARS-CoV-2
genome
was
found
to
mutate
rapidly
due
sustained
transmission
potentially
animals,
resulting
variants
concern
(VOCs)
that
threaten
global
health.
However,
primary
difficulties
are
filling
current
knowledge
gaps
terms
origin
modalities
for
these
viruses.
Because
many
CoVs
threatening
health
suspected
a
zoonotic
origin,
identifying
animal
hosts
implicated
spillover
or
spillback
events
would
be
beneficial
pandemic
management
prevent
future
outbreaks.
In
this
review,
wesummarize
models,
reservoirs,
cross-species
CoVs.
Finally,
we
comment
on
potential
sources
Omicron
VOCs
new
recombinants
currently
under
investigation.
Emerging Microbes & Infections,
Год журнала:
2022,
Номер
11(1), С. 662 - 675
Опубликована: Фев. 2, 2022
Severe
acute
respiratory
syndrome
coronavirus
2
(SARS-CoV-2)
is
responsible
for
a
global
pandemic
that
has
had
significant
impacts
on
human
health
and
economies
worldwide.
SARS-CoV-2
highly
transmissible
the
cause
of
disease
2019
in
humans.
A
wide
range
animal
species
have
also
been
shown
to
be
susceptible
by
experimental
and/or
natural
infections.
Sheep
are
commonly
farmed
domestic
ruminant
not
thoroughly
investigated
their
susceptibility
SARS-CoV-2.
Therefore,
we
performed
vitro
vivo
studies
which
consisted
infection
ruminant-derived
cells
challenge
sheep
investigate
Our
results
showed
sheep-derived
kidney
support
replication.
Furthermore,
demonstrated
limited
with
viral
RNA
shed
nasal
oral
swabs
at
1
3-days
post
(DPC);
was
detected
tract
lymphoid
tissues
4
8
DPC.
Sero-reactivity
observed
some
principal
infected
but
contact
sentinels,
indicating
transmission
co-mingled
naïve
efficient;
however,
sentinel
animals
21
used
inoculum
consisting
mixture
two
isolates,
representatives
ancestral
lineage
B.1.1.7-like
alpha
variant
concern,
study
competition
virus
strains.
indicate
show
low
outcompeted
strain.